PCV87 COST-EFFECTIVENESS OF PROTON PUMP INHIBITORS FOR PREVENTION OF GASTROINTESTINAL ADVERSE EVENTS WHEN USING ASPIRIN FOR PRIMARY CARDIOVASCULAR PREVENTION
Abstract
Authors
S Earnshaw M Pignone AM Fendrick JM Scheiman C McDade